The next act for mRNA: pushing boundaries in cell and gene therapy
Dr Cody Palumbo at TriLink BioTechnologies says the race is on to bring mRNA-based gene editing drugs to market.
TriLink BioTechnologies
Advancing lifechanging medicine: gRNA in the spotlight
Cell and gene therapy market outlook strong despite technical challenges
Building up the infrastructure for future pandemic preparedness: Frontiers in rapid raw material production
Enhancing mRNA drug development: how to optimise your suppliers and materials
Self-amplifying RNA and vaccine innovation: getting from concept to clinic
The new technologies helping biopharmaceutical trailblazers accelerate progress from research to market
Innovations Powering the Future of mRNA: What Biomanufacturers Need to Know
